首页> 外文期刊>Electrophoresis: The Official Journal of the International Electrophoresis Society >Identification of the proteomic variations of invasive relative to non-invasive non-functional pituitary adenomas
【24h】

Identification of the proteomic variations of invasive relative to non-invasive non-functional pituitary adenomas

机译:相对于非侵袭性非功能性垂体瘤的侵袭性蛋白质组学变异的鉴定

获取原文
获取原文并翻译 | 示例
       

摘要

The incomplete surgery section of invasive non-functional pituitary adenomas (NFPAs) carries the increased risks of complications and requires adjuvant radiotherapy and medications. It is necessary to clarify the molecular mechanisms and markers of invasiveness to guide the management of NFPA patients. The study aimed to proteomic variations of invasive and non-invasive NFPAs and sought the protein markers for invasive NFPAs. Invasive (n = 4) and non-invasive (n = 4) NFPA tissues were analyzed (n = 3-5/each tissue) with 2DE and PDQuest software. Twenty-four high-resolution 2DE gels were quantitatively compared to determine differentially expressed proteins (DEPs) between invasive and non-invasive NFPAs. Approximately 1200 protein spots were detected in each 2DE map, and 103 differential spots (64 upregulated and 39 downregulated) were identified. Among those 103 differential spots, 57 DEPs (30 upregulated and 27 downregulated) were characterized with peptide mass fingerprint and MS/MS. Gene-ontology (GO) and ingenuity pathway analyses of those DEPs revealed pathway networks including mitochondrial dysfunction, oxidative stress, mitogen-activated protein kinase signaling abnormality, TR/RXR activation, proteolysis abnormality, ketogenesis and ketolysis, cyclin-dependent kinase C signaling abnormality, and amyloid processing that were significantly associated with invasive characteristics of invasive NFPA. Those data demonstrate that proteomic variations exist between invasive and non-invasive NFPAs. 2DE-based comparative proteomics is an effective approach to identify proteomic variations and pathway network variations. Those findings will serve as a basis to understand the molecular mechanisms of invasive NFPAs and to discover protein markers to effectively manage patients with invasive NFPAs.
机译:侵袭性非功能性垂体腺瘤(NFPAs)的不完全手术部分增加了并发症的风险,需要辅助放疗和药物治疗。有必要阐明侵袭性的分子机制和标志物,以指导NFPA患者的治疗。这项研究旨在研究侵入性和非侵入性NFPA的蛋白质组学变异,并寻求侵入性NFPA的蛋白质标记。使用2DE和PDQuest软件分析了侵入性(n = 4)和非侵入性(n = 4)NFPA组织(n = 3-5 /每个组织)。定量比较了二十四种高分辨率2DE凝胶,以确定侵入性和非侵入性NFPA之间的差异表达蛋白(DEP)。在每个2DE图谱中检测到大约1200个蛋白质斑点,并鉴定出103个差异斑点(上调64个,下调39个)。在这103个差异点中,用肽质量指纹图谱和MS / MS表征了57个DEP(上调30个,下调27个)。这些DEP的基因本体论(GO)和独创性途径分析揭示了途径网络,包括线粒体功能障碍,氧化应激,丝裂原激活的蛋白激酶信号传导异常,TR / RXR活化,蛋白水解异常,生酮和酮分解,细胞周期蛋白依赖性激酶C信号传导异常以及淀粉样蛋白加工与有创NFPA的侵入特性显着相关。这些数据表明,在侵入性和非侵入性NFPA之间存在蛋白质组变异。基于2DE的比较蛋白质组学是识别蛋白质组变异和途径网络变异的有效方法。这些发现将作为基础,以了解侵入性NFPA的分子机制,并发现蛋白质标记物以有效管理患有侵入性NFPA的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号